Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
0(0%)
Results Posted
22%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_3
2
20%
Ph phase_2
4
40%
Ph phase_1
4
40%

Phase Distribution

4

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
4(40.0%)
Phase 2Efficacy & side effects
4(40.0%)
Phase 3Large-scale testing
2(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(9)
Terminated(1)

Detailed Status

Completed9
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
90.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (40.0%)
Phase 24 (40.0%)
Phase 32 (20.0%)

Trials by Status

completed990%
terminated110%

Recent Activity

0 active trials
Showing 5 of 10
completedphase_1

Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate

NCT02064036
completedphase_3

Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

NCT00005044
completedphase_2

Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment

NCT00165399
terminatedphase_3

Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial

NCT00243646
completedphase_2

Degarelix Neo-Adjuvant Radical Prostatectomy Trial

NCT01674270
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT02064036Phase 1

Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate

Completed
NCT00005044Phase 3

Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Completed
NCT00165399Phase 2

Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment

Completed
NCT00243646Phase 3

Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial

Terminated
NCT01674270Phase 2

Degarelix Neo-Adjuvant Radical Prostatectomy Trial

Completed
NCT00631527Phase 1

Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer

Completed
NCT01250717Phase 2

Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer

Completed
NCT00637871Phase 2

Casodex - Nolvadex Combination

Completed
NCT00972855Phase 1

Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fed Conditions

Completed
NCT00973050Phase 1

Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fasting Conditions

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10